Morning Breakouts

Latest KFF Health News Stories

In Latest Swipe At Health Law, ACO Program That Failed To Save Government Billions Will Be Overhauled

Morning Briefing

Accountable care organizations were set up under the Affordable Care Act with the intention of improving quality and efficiency. But government data shows that they’ve fallen short of the savings that were projected. “After six years of experience, the time has come to put real ‘accountability’ in Accountable Care Organizations,” CMS Administrator Seema Verma said in a statement. “Medicare cannot afford to support programs with weak incentives that do not deliver value.”

Southern California Gas Co. To Pay For Study Into Health Consequences Of Leak As Part Of $120M Settlement

Morning Briefing

Residents near the leak have complained of nausea, headaches and nosebleeds after a ruptured well began spewing gas as well as benzene and other air toxics in October 2015. It took nearly four months to seal the well, and residents have since filed hundreds of lawsuits against the company.

‘End Family Fire’: Advocates Want To Curb Children’s Deaths From Accidental Shootings By Giving The Problem A Name

Morning Briefing

“Just like the term ‘designated driver’ changed perceptions about drinking and driving, the term ‘Family Fire’ will help create public awareness to change attitudes and actions around this important matter,” said Kris Brown, co-president of the Brady Campaign to Prevent Gun Violence. In other public health news: online dating, dementia, sperm count, suicide, and heart health.

Insys To Pay $150M To Settle Criminal, Civil Investigation Into Marketing Techniques For Its Opioids

Morning Briefing

The company has figured prominently in the ongoing federal investigation into drugmakers’ role in the opioid epidemic because several former executives and employees have been arrested in connection with allegations of bribing doctors to boost sales of Subsys, its product that contains fentanyl. News on the crisis comes out of New York and Massachusetts, as well.

Planned Parenthood’s #DearSenators Campaign Against Kavanaugh Highlights Women’s Personal Abortion Stories

Morning Briefing

The national ad campaign includes Alaska and Maine, whose senators have a history of supporting abortion rights and are being watched closely for their votes on Brett Kavanaugh’s nomination to the Supreme Court. Meanwhile, in Connecticut, a panel discusses what would happen if Roe v. Wade is overturned.

Would A ‘Netflix’ Subscription Model Work For Pricey Hep C Drugs? Louisiana Wants To Find Out

Morning Briefing

The state would pay a fixed amount of money for the drugs for a certain amount of time. While some are praising the effort, other experts say that because costs are coming down already, that it’s unclear whether that type of deal would really save the state money.

CVS Wants Pharma To Stop Pointing Fingers At The Middlemen When It Comes To High Drug Prices

Morning Briefing

“Drug manufacturers want you to believe that increasing drug prices are a result of them happy to pay rebates and that PBMs are retaining these rebates. And this is simply not true,” said Larry Merlo, the CEO of CVS, which owns Caremark, one of the biggest pharmacy-benefit managers. Meanwhile, the American Medical Association speaks out against CVS’ attempts to acquire insurer Aetna. And Rite Aid and Albertsons call off their merger.

Medicare’s Power To Negotiate Drug Prices Will Harm Patients With Chronic Illnesses, Advocates Warn

Morning Briefing

Medicare Advantage’s negotiating tool — requiring patients to try lower-cost treatments before the more expensive ones — is derided as a “fail first” process to those who oppose the strategy. “Consumers may have to go through one or more drugs before they can get a particular treatment they really need,” said Ellen Albritton, a senior policy analyst at Families USA. Meanwhile, there are already signals that implementing the new rules is going to be complicated.

Rep. Chris Collins Indicted On Charges Related To Insider Trading Following Probe Into His Ties To Drugmaker

Morning Briefing

Rep. Chris Collins (R-N.Y.) is alleged to have passed inside information on the failure of an Innate Immunotherapeutics’ drug trial to his son, who then passed it to another alleged conspirator. Collins describes the charges as “merit-less” and says he will stay in office and run for reelection. Meanwhile, House Speaker Paul Ryan says that Collins would not serve on the House Energy and Commerce Committee “until this matter is settled.”

Rep. Chris Collins Indicted On Charges Related To Insider Trading Following Probe Into His Ties To Drugmaker

Morning Briefing

Rep. Christopher Collins (R-N.Y.) is alleged to have passed inside information on the failure of a Innate Immunotherapeutics’ drug trial to his son, who then passed it to another alleged conspirator. The three avoided about $768,000 in losses as a result of the information, prosecutors allege.